Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.
- 1 December 1985
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (24), 8648-8652
- https://doi.org/10.1073/pnas.82.24.8648
Abstract
Antibodies to the clonally unique variable-region determinants (idiotype) of the antigen-specific alpha beta heterodimeric receptor of a clone of cytotoxic T cells (CTLs) were shown previously to render diverse cells, regardless of their own surface antigens, susceptible to lysis by that clone of CTLs. To extend these findings, we have sought to develop a general means for targeting cells for destruction by any CTL, without regard to its alpha beta idiotype and specificity for antigen. We explored the use of heteroantibody duplexes formed by joining covalently an antibody to the T3 complex (anti-T3), which is associated with the alpha beta receptors on all human mature T cells, and a second antibody, specific for an antigen on the intended target cell. The second antibody selected in this study was specific for the idiotype (Id) of the surface immunoglobulin of a human B-lymphoma (anti-Ig Id). In the presence of the anti-T3/anti-Ig Id heteroantibody duplex the B-lymphoma cells were lysed by a clone of human T8+ CTLs (of unrelated specificity) but not by a noncytotoxic clone of human T4+ helper T cells, and lysis by the CTLs was specifically blocked by the uncoupled anti-T3 or the uncoupled anti-Ig Id antibodies. The extent of the heteroantibody-dependent cytolysis depended both on the heteroantibody concentration and on whether the intended target cells or the CTL effectors were initially preincubated with the heteroantibody. Under optimal conditions, heteroantibody-dependent lysis of the surrogate target (B-lymphoma) cells by the CTLs compared favorably with lysis of their natural target cells by the same CTLs. Overall, our findings suggest that heteroantibody duplexes containing anti-T3 antibody may be capable of targeting selected cells, such as tumor cells, for destruction in vivo by the body's CTLs.Keywords
This publication has 18 references indexed in Scilit:
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985
- Hybrid antibodies can target sites for attack by T cellsNature, 1985
- Cross-linking of human T cell receptor proteins: association between the T cell idiotype β subunit and the T3 glycoprotein heavy subunitCell, 1985
- Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1984
- Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.The Journal of Experimental Medicine, 1984
- Internal Disintegration Model of Cytotoxic Lymphocyte‐Induced Target DamageImmunological Reviews, 1983
- Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.The Journal of Experimental Medicine, 1983
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982
- Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagentBiochemical Journal, 1978
- Preparation of protein conjugates via intermolecular disulfide bond formationBiochemistry, 1978